Inventor · disambiguated record
Jennifer Iaci
Also filed as: IACI JENNIFER · IACI JENNIFER F
23 granted patents·14 pending applications·39 citations·filing 2003–2022
94Inventor score
Top patents by PatentIndex Score
37 records- 0192US9198951B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2013·Granted Dec 1, 2015·10 cites·5 claims
- 0286US9956266B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·2 cites·12 claims
- 0383US7485295B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2006·Granted Feb 3, 2009·4 cites·13 claims
- 0481US9410141B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·2 cites·16 claims
- 0581US7722864B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2007·Granted May 25, 2010·3 cites·32 claims
- 0679US7731956B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 8, 2010·2 cites·13 claims
- 0778US9102930B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·2 cites·21 claims
- 0877US8852583B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2012·Granted Oct 7, 2014·2 cites·25 claims
- 0976US8404232B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2010·Granted Mar 26, 2013·2 cites·51 claims
- 1076US8236302B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2010·Granted Aug 7, 2012·2 cites·13 claims
- 1176US8183350B2Compositions and methods for promoting neuronal outgrowthGRUSKIN ELLIOTT A·Filed 2003·Granted May 22, 2012·4 cites·7 claims
- 1275US2011166068A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1373US9498515B2Compositions and methods for treatment during non-acute periods following CNS neurological injuryCAGGIANO ANTHONY·Filed 2009·Granted Nov 22, 2016·2 cites·16 claims
- 1471US9468671B2Compositions and methods for promoting neuronal outgrowthACORDA THERAPEUTICS INC·Filed 2014·Granted Oct 18, 2016·0 cites·9 claims
- 1571US8785606B2Compositions and methods for promoting neuronal outgrowthGRUSKIN ELLIOTT A·Filed 2012·Granted Jul 22, 2014·1 cites·21 claims
- 1669US11235031B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2019·Granted Feb 1, 2022·0 cites·15 claims
- 1768US2023117985A1Use of neuregulin to treat peripheral nerve injuryACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1868US2018280477A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1966US10668131B2Compositions and methods for treatment during non-acute periods following CNS neurological injuryACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 2, 2020·0 cites·7 claims
- 2064US9956273B2Compositions and methods for promoting neuronal outgrowthACORDA THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·0 cites·10 claims
- 2164US9402886B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2014·Granted Aug 2, 2016·0 cites·8 claims
- 2264US8906363B2Fusion proteins for the treatment of CNSGRUSKIN ELLIOTT A·Filed 2004·Granted Dec 9, 2014·1 cites·8 claims
- 2364US2020368318A1Compositions and methods for treatment during non-acute periods following cns neurological injuryACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2464US2018073007A9Fusion proteins for the treatment of cnsACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2563US10323240B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·0 cites·11 claims
- 2662US2020338165A1Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2761US9987340B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 5, 2018·0 cites·12 claims
- 2860US9834764B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·0 cites·10 claims
- 2955US2016129084A1Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3054US2018303904A1Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3154US2016058743A1Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridinesACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3251US2015094263A1Use of Neuregulin to Treat Peripheral Nerve InjuryACORDA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3351US2018311312A1Use of a Neuregulin to Treat Peripheral Nerve InjuryACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3448US9078861B2Use of a neuregulin to treat peripheral nerve injuryCAGGIANO ANTHONY O·Filed 2010·Granted Jul 14, 2015·0 cites·7 claims
- 3545US2016346353A1Use of Neuregulin to Treat Peripheral Nerve InjuryACORDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3643US2016067232A1Methods for treating a stroke-related sensorimotor impairment using aminopyridinesACORDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3741US2015216936A1Use of a Neuregulin to Treat Peripheral Nerve InjuryACORDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer Iaci files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →